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Abstract
Background: The diagnosis of tuberculosis (TB) in resource-limited settings relies on Ziehl-Neelsen (ZN) smear microscopy.
LED fluorescence microscopy (LED-FM) has many potential advantages over ZN smear microscopy, but requires evaluation
in the field. The aim of this study was to assess the sensitivity/specificity of LED-FM for the diagnosis of pulmonary TB and
whether its performance varies with the timing of specimen collection.
Methods and Findings: Adults with cough $2 wk were enrolled consecutively in Ethiopia, Nepal, Nigeria, and Yemen.
Sputum specimens were examined by ZN smear microscopy and LED-FM and compared with culture as the reference
standard. Specimens were collected using a spot-morning-spot (SMS) or spot-spot-morning (SSM) scheme to explore
whether the collection of the first two smears at the health care facility (i.e., ‘‘on the spot’’) the first day of consultation
followed by a morning sample the next day (SSM) would identify similar numbers of smear-positive patients as smears
collected via the SMS scheme (i.e., one on-the-spot-smear the first day, followed by a morning specimen collected at home
and a second on-the-spot sample the second day). In total, 529 (21.6%) culture-positive and 1,826 (74.6%) culture-negative
patients were enrolled, of which 1,156 (49%) submitted SSM specimens and 1,199 (51%) submitted SMS specimens. Single
LED-FM smears had higher sensitivity but lower specificity than single ZN smears. Using two LED-FM or two ZN smears per
patient was 72.8% (385/529, 95% CI 68.8%–76.5%) and 65.8% (348/529, 95% CI 61.6%–69.8%) sensitive (p,0.001) and 90.9%
(1,660/1,826, 95% CI 89.5%–92.2%) and 98% (1,790/1,826, 95% CI 97.3%–98.6%) specific (p,0.001). Using three LED-FM or
three ZN smears per patient was 77% (408/529, 95% CI 73.3%–80.6%) and 70.5% (373/529, 95% CI 66.4%–74.4%, p,0.001)
sensitive and 88.1% (95% CI 86.5%–89.6%) and 96.5% (95% CI 96.8%–98.2%, p,0.001) specific. The sensitivity/specificity of
ZN smear microscopy and LED-FM did not vary between SMS and SSM.
Conclusions: LED-FM had higher sensitivity but, in this study, lower specificity than ZN smear microscopy for diagnosis of
pulmonary TB. Performance was independent of the scheme used for collecting specimens. The introduction of LED-FM
needs to be accompanied by appropriate training, quality management, and monitoring of performance in the field.
Trial Registration: Current Controlled Trials ISRCTN53339491
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Introduction
Tuberculosis (TB) is a major public health problem: there are
9.3 million new cases and 1.7 million deaths per year [1], with
90% of cases occurring in low- and middle-income countries
(LMICs) [1]. Most patients suspected of having pulmonary TB
(PTB) in LMICs are investigated by examining three sputum
specimens collected over a minimum of 2 d. Sputum smears are
stained with Ziehl-Neelsen (ZN), and each smear examination
requires on average 5–10 min, creating considerable workloads for
laboratories with limited resources. An alternative technique to
ZN smear microscopy, fluorescence microscopy (FM), is reported
to be 10% more sensitive than ZN smear microscopy [2] and,
since fluorescent acid fast bacilli (AFB) can be seen at lower
magnification than ZN-stained AFB, FM smears can be examined
in a fraction (about 25%) of the time needed for ZN smears [2].
Although FM can reduce laboratory workloads [3], it has been
difficult to implement it widely in LMICs due to the high cost and
complexity of the microscope and mercury vapour lamp lighting
system, the need for a dark room, and perceived health risks
associated with ultraviolet light exposure [4].
Recent technical developments have the potential to improve
some of the shortcomings of the smear diagnosis of TB. These
include the development of illumination systems based on LEDs
(light-emitting diodes), which resulted in LED fluorescence
microscopy (LED-FM) becoming commercially available [5].
Furthermore, the World Health Organization (WHO) recently
modified its guidelines for the diagnosis of PTB [6] and reduced
the number of AFB required to declare a smear as positive (from
10 to 1 AFB), the minimum number of specimens needed for
diagnosis (from three to two), and the number of positive smears
required to classify a patient as having smear-positive TB (from
two to one smear). In a separate publication (also reported in PLoS
Medicine [7]), we report that the ZN smear microscopy examina-
tion of two sputum specimens collected on the spot the first day of
consultation, followed by the examination of a third specimen
collected the following morning (i.e., spot-spot-morning [SSM])
identifies the same number of patients with smear-positive PTB as
the frequently used spot-morning-spot (SMS) scheme (i.e.,
examination of one sputum specimen collected on the spot the
first day of consultation, followed by the examination of a second
specimen collected the following morning and a third specimen
collected on the spot when the patient brings the morning
specimen to the health centre) [8]. As most smear-positive PTB
patients are identified by the first two specimens [9], a SSM
scheme could detect most smear-positive patients on the first day
of consultation. It is thus conceivable that a service that examines
SSM specimens using LED-FM and classifies patients using the
revised WHO guidelines could ease workloads and speed up the
diagnostic process in LMICs, with significant benefits for patients
and health systems [3].
We therefore conducted a study, nested within a clinical trial,
assessing the sensitivity and specificity of LED-FM using both
SSM and SMS sputum collection schemes for the diagnosis of
PTB.
Methods
The protocol for the trial was registered (ISRCTN53339491),
and ethical approval was obtained from the Liverpool School of
Tropical Medicine and WHO ethics review committees, the
institutional review boards, and respective national research ethics
committees of the participating centres (see Text S1). Translated
consent forms and patient information sheets were used for each
site. Informed written or oral consent in front of a witness were
obtained from all patients. Patients unable to provide informed
consent and those who had received anti-TB treatment in the last
month were excluded.
This was a prospective cross-sectional study carried out in
Ethiopia, Nepal, Nigeria, and Yemen over a 15-mo period from 3
January 2008 to 30 March 2009 (see Text S2). The study was nested
within a non-inferiority clinical trial assessing whether the sensitivity
and specificity of ZN smear microscopy of sputum specimens
collected under a SSM scheme were non-inferior to those of ZN
smear microscopy following the standard SMS collection scheme for
the diagnosis of PTB, which is also published in this issue [7]. The
study sites were selected to obtain a wide geographical representation
of LMIC settings and took advantage of a larger clinical trial on
smear microscopy being undertaken at the same time. This facilitated
training, as well as the use of protocols and standard operating
procedures across locations.
All consecutive patients $18 y old with cough $2 wk duration
presenting at participating health facilities were screened and
invited to participate in the clinical trial. Of these, only the first 7–
10 patients attending the health care centres each day were invited
to participate in the LED-FM evaluation to avoid overloading the
laboratories (see Figure 1). It is recognised that selecting the first
patients may have introduced systematic biases (e.g., residents of
nearby households with mild illnesses or those from remote
locations with advanced disease stages). Random selection,
however, was logistically difficult. The data obtained for smear
microscopy (ZN and LED-FM) were paired and therefore
relatively independent of the actual representativeness of the
participants in relation to the reference population.
Patients enrolled in Ethiopia were attending Bushullo Major and
Awassa Health Centres. These are the main health service providers
for Awassa District in the Southern Region. Smear microscopy was
conducted in the health centres’ laboratories, and sputum specimens
were cultured at the Armauer Hansen Institute, Addis Ababa.
Patients in Abuja, Nigeria, were enrolled in Wuse District Hospital,
and sputum specimens were processed in the Zankli Medical Centre
laboratory, a private laboratory acting as a diagnostic centre for the
National Tuberculosis Programme. In Nepal, patients were enrolled
from the TB DOTS centre of Tribhuvan University Teaching
Hospital and the Dirgh Jeevan Health Care and Research Centre,
both in Kathmandu. Sputum specimens collected in both centres
were processed in Tribhuvan University Health Research Labora-
tory. In Yemen, patients were enrolled at the Tuberculosis Institute,
which is the reference centre and headquarters of the National
Tuberculosis Programme and which provides diagnostic services to
the surrounding population and referred patients.
All patients were requested to submit three sputum specimens
following one of the two schemes. One scheme required patients to
provide a sputum sample on first attendance at the health facility,
a second sample (which was produced at home) the following
morning, and a third sample collected on the spot when the
patient brought the morning specimen to the laboratory (SMS).
The second scheme required patients to provide a specimen on the
spot upon first attendance at the health care facility, a second
specimen one hour after the first specimen, and a third specimen
that was produced at home the following morning (SSM). The
schemes were allocated by week using a randomization list that
assigned the scheme to be used in a given week. The scheme was
disclosed at the start of the week by opening a sealed envelope.
Patients were provided with pre-labelled sputum collection pots
and instructed on how to produce a good quality sputum specimen
following a standard operating procedure [10].
Specimens were assessed macroscopically, and smears were
prepared in duplicate for staining by the hot ZN technique or with
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Auramine O, counterstained with potassium permanganate, for
FM [11]. Slides were labelled with study numbers. These labels
were then covered with wrap-around stickers before mixing and
reading to ensure laboratory technicians were unaware of the
grades assigned to previous smears. Grading was conducted by
laboratory technicians, and the stickers were removed when
another technician entered the results into the study logbooks.
LED-FM was conducted on standard microscopes fitted with
adaptors consisting of a specialised objective with an attached
LED light source (LUMIN and the QBC Paralens Fluorescence
Figure 1. Depiction of flow of participants.
doi:10.1371/journal.pmed.1001057.g001
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Microscopy System). ZN smears were examined at 1,0006
magnification, and LED-FM smears (in accordance with advice
from the International Union Against Tuberculosis and Lung
Disease Working Group on Smear Microscopy) at 2006, with
confirmation of positive smears at 4006 magnification. Smears
were classified as positive when $1 AFB was detected per 100
fields, and patients were considered smear-positive if they had $1
positive smear [6]. Patients with missing results were classified
according to the results of available smears (e.g., patients with two
negative smears but missing the third specimen were classified as
negative). The morning specimen, or, if not available, a spot
specimen, was concentrated (Petroff’s method) and cultured on
solid medium. Identification of Mycobacterium tuberculosis complex
was confirmed by standard biochemical tests [11].
The study was implemented at each site after training and a
pilot phase, and was conducted in compliance with good clinical
practice/good clinical laboratory practice. A lot quality assurance
sampling scheme was used to determine the sample size for ZN
smear microscopy external quality assessment (EQA) to assure a
sensitivity of 90% relative to the controller, with a maximum of
two errors [12]. Sampling for ZN smear microscopy EQA was
performed before, during, and at the end of the study and was
conducted by WHO/International Union Against Tuberculosis
and Lung Disease Supranational Reference Laboratories. A
random selection of 20% LED-FM smears from all sites was also
selected for EQA. In addition, all LED-FM smears graded as
scanty (,10 AFB per 100 fields) were sent to Supranational
Reference Laboratories and the German-Nepal Tuberculosis
Project in Nepal at the end of the study, where smears were re-
stained and re-checked using conventional FM. The main
outcomes for comparison were the sensitivity and specificity of
LED-FM compared with the sensitivity and specificity of ZN
smear microscopy. Culture was used as the reference standard,
and the analysis was stratified by scheme. As LED-FM smears with
scanty AFB (,10 AFB) were often reported negative by
conventional FM, both results are presented, stratified by culture
to assign true-/false-positive results. It is however acknowledged
that this partial verification could result in an inaccurate estimate
of test performance and that this latter sub-analysis needs to be
interpreted with caution.
Data are presented using summary statistics with 95% CI.
Comparisons of the characteristics of the patients studied in the
four participating countries were by one-way analyses of variance
for continuous measures and Fisher exact tests for categorical
measures. Comparisons of sensitivity and specificity values where
both methods were applied to the same samples (i.e., the
observations were paired) were done using the McNemar test;
comparisons where samples were taken from two different
(independent) cohorts were done using the Fisher exact test. The
sample size calculations for the study assumed that ZN smear
microscopy would identify 50% of culture-positive patients and
that LED-FM would be 10% more sensitive than ZN smear
microscopy [2]. The target sample size of 1,605 was assumed to be
an overestimate of the number required because the calculations
presumed that specimens were not paired. Although studies
evaluating paired samples have lower minimum sample sizes
required than studies using independent samples, the overestima-
tion was unavoidable without prior knowledge of the expected test
discordance.
Results
A total of 2,445 patients (37% of 6,628 patients enrolled for the
larger trial [7]) were enrolled for the LED-FM evaluation. Of
these, 468 (19%) were enrolled in Ethiopia, 526 (22%) in Nepal,
685 (28%) in Nigeria, and 766 (31%) in Yemen. The character-
istics of the participants are summarised in Table 1. More
participants (1,294, 53%) were male, and the majority were
married (1,679, 69%). Participants in Nepal and Yemen were
older (mean [standard deviation] of 43.6 [17.7] and 41 [17.9] y)
than participants in Ethiopia and Nigeria (34.9 [14.3] and 34.3
[11.1] y, respectively, p,0.001). Patients in Ethiopia and Yemen
were more likely to come from rural areas (58% and 51%) than
patients in Nepal and Nigeria (7% and 13%, p,0.001), and
patients in Nepal presented with longer cough duration than
patients in the other three countries. The most frequent
complaints were cough, chest pain, weight loss, anorexia, fever,
and night sweating. Of the 2,445 patients enrolled, 529 (21.6%)
were culture-positive, 1,826 (74.6%) were culture-negative, and 90
(3.7%) had invalid culture results (57 [2.3%] contaminated and 33
[1.4%] missing). Among patients with positive or negative cultures,
1,156 (48.9%) were screened using the SSM scheme and 1,199
(51.1%) the SMS scheme.
Individual ZN and LED-FM smear results by type of specimen
are described in Text S3. Smears prepared from the morning
specimens were more likely to be positive than smears prepared
from spot specimens. Among culture-positive patients, ZN smears
were less likely to be positive than LED-FM smears (937/1,568
[59.8%, 95% CI 57.3%–62.2%] and 1,051/1,531 [68.7%, 95%
CI 66.3%–71.0%], respectively, p,0.001). Among culture-nega-
tive patients, ZN smears were more likely to be negative than the
LED-FM smears (5,263/5,349 [98.4%, 95% CI 98%–98.7%] and
4,816/5,118 [94.1%, 95% CI 86.4%–88.1%], respectively,
p,0.001). Single LED-FM smears therefore had higher sensitivity
but lower specificity than single ZN smears. Out of 283 LED-FM
smears with scanty grades that had paired conventional FM
readings, 136 (48.1%) were culture-positive and 147 (51.9%)
culture-negative according to conventional FM. Ninety-six
(70.6%) of the culture-positive specimens were graded positive
and 77 (52.3%) of the 147 culture-negative specimens were graded
negative by conventional FM. LED-FM smears therefore were
more sensitive but less specific than conventional FM smears for
classifying smears with low AFB numbers. The sensitivity/
specificity obtained after incorporating the revised scanty smears
in the analysis is shown in Table 2 for illustration.
Using two or three LED-FM smears per patient resulted in
sensitivities (95% CI) of 72.8% (68.8%–76.5%) and 77.1%
(73.3%–80.6%), compared to 65.8% (61.6%–69.8%) and 70.5%
(66.4%–74.4%) when using two or three ZN smears (p,0.001 for
both). Using two or three LED-FM smears per patient produced
specificities (95% CI) of 90.9% (89.5%–92.2%) and 88.1%
(86.5%–89.6%), respectively, compared to 98% (97.3%–98.6%)
and 96.5% (96.8%–98.2%) when using two or three ZN smears
(p,0.001 for both). The accuracy of using three LED-FM smear
examinations per patient was 85% (2,017 of 2,355 patients
correctly classified, 95% CI 84.2%–87%), which was lower than
the 91.8% accuracy obtained when using three ZN smear
examinations (2,136 of 2,355 patients, 95% CI 89.5%–91.8%,
p,0.001). An illustration of the proportion of true- and false-
positive and -negative results obtained with ZN smear microscopy
and LED-FM using two and three smears is included in Table 3
for illustration. The use of two ZN smears would correctly classify
the highest number of patients (91%), but would also miss the
highest number of cases with TB, and, conversely, using three
LED-FM smears would have the lowest number of cases classified
correctly (85%), but would miss the lowest number of cases with
TB, thus the increased sensitivity is at the expense of lower
specificity. The sensitivity and specificity of the SSM and SMS
LED-FM for the Diagnosis of TB
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schemes for both LED-FM and ZN smear microscopy are shown
in Text S3. There were no statistical differences between the
schemes.
Discussion
The number of cases of PTB continues to increase worldwide
despite major international control initiatives [1], and at least 50
million individuals with chronic cough are screened for TB each
year. Although it is widely accepted that the early identification of
cases through inexpensive point-of-care diagnostics is pivotal for
effective control of TB, the diagnosis of PTB often relies on
sputum smear microscopy, especially in resource-limited settings.
Sputum smear microscopy services are the most decentralized
of the TB diagnostic services, allowing patients to be screened for
tuberculosis at relatively basic health care facilities. In most
LMICs, however, these centres are less numerous than treatment
centres, and many patients still need to travel to submit sputum
specimens for diagnosis, incurring considerable personal costs, and
this often leads patients to abandon the process. The diagnosis of
TB therefore is particularly difficult for poor and marginalised
patients, who face multiple challenges to accessing a TB diagnosis
[13], and the improvement of smear microscopy services remains
necessary to increase patients’ access to treatment [14]. Further-
more, smear microscopy is known to be less sensitive in HIV-
associated tuberculosis, and interventions which could increase this
sensitivity are needed.
LED-FM holds multiple advantages over both the conventional
mercury vapour lamp FM and standard light microscopy. LEDs are
relatively inexpensive, can be powered by mains or batteries, and
have an effective lifespan of thousands of hours [5]. The longer
lifespan of the LED systems, as well as facilitating their implemen-
tation, may result in better quality FM than conventional systems
since mercury vapour and halogen lamps are often used after their
effective lifespan, with diminished power, to cause fluorescence. The
lower capital and maintenance costs of LED-based systems, the faster
grading of smears than with ZN smear microscopy, and FM’s reputed
higher sensitivity makes LED-FM devices potentially more suitable
for LMIC laboratories. Despite this potential, there have been very
few well-designed field evaluations using culture as the reference
standard [2,15] to assess whether LED-FM performance varies in
locations with no or limited experience with FM.
LED-FM in this study had higher sensitivity but lower specificity
than ZN smear microscopy, which resulted in a significantly
Table 1. Characteristics of the patients on enrolment.
Characteristic Sub-Category Ethiopia (n=468) Nepal (n=526) Nigeria (n=685) Yemen (n=766) All (n=2,445)
Age, mean (SD) 34.9 (14.3) 43.6 (17.7) 34.3 (11.1) 41 (17.9) 38.6 (16.1)
Sex Male 243 (52.5) 344 (65) 319 (46.6) 388 (59.6) 1,294 (52.9)
Female 220 (47.5) 182 (35) 353 (51.5) 378 (49.3) 1,133 (46.3)
Unknown 5 0 13 0 17 (0.7)
Marital status Single 87 (18.5) 85 (16.2) 237 (34.5) 133 (17.4) 542 (22.2)
Married 317 (67.7) 439 (83.5) 371 (54.1) 552 (72) 1,679 (68.7)
Separated/widowed 5 (1) 2 (0.4) 64 (9.3) 81 (10.5) 152 (6.2)
Unknown 59 (11.6) 0 13 (1.9) 0 72 (2.9)
Residence Rural 273 (58.3) 39 (7.4) 90 (13.1) 388 (50.7) 790 (32.3)
Study town 116 (24.8) 238 (45.2) 549 (81.1) 352 (46) 1,255 (51.3)
Other town 49 (10.5) 249 (47.3) 33 (4.8) 26 (3.4) 357 (14.6)
Unknown 30 (6.4) 0 13 (1.9) 0 43 (1.8)
Education Illiterate 281 (60.0) 164 (31.2) 58 (8.5) 517 (67.5) 1,020 (41.7)
Literate 127 (27.1) 362 (68.8) 614 (89.6) 249 (32.5) 1,352 (55.3)
Unknown 60 (12.8) 0 13 (1.9) 0 73 (3)
Signs/symptoms Cough duration 7.8 (9.2) 12.8 (13.6) 8.9 (16.7) 7.8 (11.9) 9.3 (13.5)
Chest pain 321 (68.5) 424 (80.3) 443 (64.7) 680 (88.8) 1,868 (76.4)
Weight loss 274 (58.5) 331 (62.9) 437 (63.8) 608 (79.4) 1,650 (67.5)
Fever 259 (55.3) 243 (46.2) 461 (66.3) 625 (81.6) 1,588 (64.9)
Night sweats 319 (68.1) 261 (49.6) 291 (42.5) 599 (78.2) 1,470 (60.1)
Loss of appetite 313 (66.8) 361 (68.6) 301 (43.9) 527 (68.8) 1,502 (61.4)
Haemoptysis 40 (9) 90 (17.1) 50 (7.3) 208 (27.2) 388 (15.9)
HIV Positive 4 (0.9) 2 (0.4) 236 (34.4) 0 242 (9.9)
Negative 33 (7.1) 8 (1.5) 109 (15.9) 9 (1.2) 159 (6.5)
Unknown 431 (92) 516 (98) 340 (49.6) 757 (98.8) 2,044 (83.6)
Culture Positive 159 (34) 58 (11) 120 (17.5) 192 (25.1) 529 (21.6)
Negative 270 (57.7) 444 (84.4) 551 (81) 561 (72.2) 1,826 (74.6)
Contaminated 10 (2.1) 23 (4.4) 14 (2) 10 (1.3) 57 (2.3)
Not available 29 (6.2) 1 (0.2) 0 (0) 3 (0.4) 33 (1.3)
Age in years, cough duration in weeks. p,0.01 for all variables. SD, standard deviation.
doi:10.1371/journal.pmed.1001057.t001
LED-FM for the Diagnosis of TB
PLoS Medicine | www.plosmedicine.org 6 July 2011 | Volume 8 | Issue 7 | e1001057
higher number of patients with PTB being treated, but lower
overall diagnostic accuracy, as illustrated in Text S3. Although
most previous studies are small [2,15,16], they have reported
increased sensitivity and similar specificity of LED-FM compared
with ZN smear microscopy. Recently, however, Cattamanchi et al.
suggested that LED-FM had lower specificity than conventional
ZN smear microscopy in patients co-infected with HIV in Uganda
[17], suggesting that the loss of specificity was more evident in
patients who had scanty AFB in sputum. The investigators,
however, had processed different specimens for ZN smear
microscopy and FM; thus, the interpretation of this study is
difficult [18], and further studies are needed. If these findings are
corroborated by further studies, however, it is still important to
consider that if a trade-off has to be made between sensitivity and
specificity, it is preferable to err on the side of increased sensitivity
and to treat a small number of patients who do not have TB.
There are real consequences to a false-positive result: patients
incorrectly diagnosed with TB have the cost and inconvenience of
taking a six-month course of treatment, and troublesome side
effects are common, but life-threatening treatment-related events
(hepatitis and Stevens-Johnson syndrome) are infrequent (,5%
incidence). It is also necessary to discuss whether solid culture, or
liquid culture, can function as an adequate comparator, as neither
is a perfect reference standard, and the underlying assumption that
either culture system has higher specificity than smear microscopy
might be debatable. The WHO manual for laboratory services in
TB control states that the probability of obtaining a positive
culture is related to the number of AFB in the specimen, with only
about 50% of cultures of specimens with 1–2 AFB per 100 fields
being identified as positive, increasing to 80% and 96.7% for
specimens with ‘‘scanty’’ (1–9 AFB per 100 fields) and ‘‘+’’ AFB
grades, respectively. The analysis of our smear-positive, culture-
negative results indicated that more than 98% of these were scanty
smears with a median of one AFB per smear, and 23.7% had a
second positive smear by either ZN smear microscopy or LED-
FM. It is thus highly likely that these patients either had
paucibacillary tuberculosis in which M. tuberculosis failed to grow
in culture, or were infected/colonised by non-tuberculous
mycobacteria. This is unfortunately an inherent weakness of solid
culture (and, to a lesser extent, liquid culture) as a diagnostic
reference standard. Judgements on the performance of new
diagnostic tests must be done with considerations of these
limitations. The ‘‘false positive’’ LED-FM results are thus most
likely due to technician error, but we cannot discount the
possibility that these were cases with TB or non-tuberculous
mycobacteria with a false-negative solid medium result that would
have been detected using liquid medium. There might also be
cases of TB that would have been missed by both culture
technologies (because of delayed processing/destruction of mar-
ginally viable bacilli during decontamination or bacterial over-
growth).
Unfortunately, HIV testing was not done systematically as part
of this study. Overall, the vast majority of patients across the sites
did not know their HIV status. The exception was the Nigerian
site, where around half of patients reported knowing their HIV
status. Only patients who volunteered this information were
categorised as HIV positive or negative. Any sub-analysis of the
results by HIV status would be underpowered, subject to self-
Table 2. Sensitivity and specificity of using two or three ZN and LED-FM smears per patient.
Number
of Smears
Smear
Resulta Culture-Positive (n=529) Culture-Negative (n =1,826)
ZN Smear
Microscopy LED-FM
After Review of
Scanty FM Smearsb
ZN Smear
Microscopy LED-FM
After Review of
Scanty FM Smearsb
2 Positive* 348 (65.8) 385 (72.8) 369 (70.0) 36 (2.0) 166 (9.1) 103 (5.7)
Negative 181 (34.2) 144 (27.2) 158 (30.0) 1,790 (98.0) 1,660 (90.9) 1,718 (94.3)
3 Positive 373 (70.5) 408 (77.1) 394 (74.5) 63 (3.5) 217 (11.9) 137 (7.5)
Negative 156 (29.5) 121 (22.9) 135 (25.5) 1,763 (96.5) 1,609 (88.1) 1,689 (92.5)
a‘‘Positive’’ defined as a patient with $1 smear with $1 AFB. Patients with incomplete sets were classified according to the smears available.
bSee description in Methods.
doi:10.1371/journal.pmed.1001057.t002
Table 3. Absolute difference the use of two- or three-smear ZN smear microscopy and LED-FM schemes would make per 1,000
persons tested in situations with similar TB prevalence.
Test Absolute Difference per 1,000 Persons
Pre-test prevalence of 21.6%a True positive True negative False positive False negative
Number with correct
diagnosis
Two-smear ZN smear microscopy 142 768 16 74 910
Two-smear LED-FM 157 713 71 59 870
Two-smear LED-FM after EQA 151 739 45 65 890
Three-smear ZN smear microscopy 152 757 27 64 909
Three-smear LED-FM 167 691 93 49 858
Three-smear LED-FM after EQA 161 725 59 55 886
aProportion of patients with culture-positive TB results observed in this study.
doi:10.1371/journal.pmed.1001057.t003
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selection bias, and confounded by the duration since last test and
the methods used for testing.
Clinical laboratories in our study had considerable experience
with ZN smear microscopy but limited experience with mercury
vapour lamp FM, and their conventional FM microscopes were
neither functioning nor in recent use at the time of the study.
Although technicians received 2-d refresher training at the bench,
were supervised for a further day to monitor performance, and
had photographic bench-aids available, ZN smear microscopy had
consistently higher specificity.
Interestingly, the rechecking of scanty smears and comparison
against culture suggests that LED-FM also had higher sensitivity
but lower specificity than conventional FM. These differences
could have been due to the devices’ performance characteristics, as
reference laboratories are equipped with high-quality microscopes
with greatly improved optics, and to the novelty of LED-FM, with
laboratory technicians conducting more careful examinations and
spending more time reading the smears to identify paucibacillary
smears, while lacking experience to distinguish fluorescing
artefacts from scanty AFB. Furthermore, technicians in the
reference laboratories routinely use dark rooms, which facilitate
visualizing the AFB in conventional FM but are not required with
LED-FM, and may have been more cautious to declare smears
with one or two bacilli as positive. Also, the smears may have
faded, and AFB could have been washed off during re-staining.
Although the comparison of LED-FM and conventional FM
was based on the verification of a partial selection of smears and
needs to be replicated, national TB control programmes
considering introducing LED-FM devices may wish to bear in
mind that their performance could vary with the service setting,
staff experience, and the type of devices used. In contrast to the
findings of this study, other studies conducted at established
research centres have found similar specificity in conventional FM
and LED-FM. Our lower specificity may thus be the upside of the
trade-off implicit in the larger amount of operational data
collected in this study, at the cost of a less-than-ideal reference
standard. The LED-FM technology, however, is likely to be widely
implemented, and the study still gives valuable insights into
operational issues. The performance of LED-FM, and indeed any
diagnostic test, depends critically on proficiency of test operators.
Adequate and appropriate training is thus required. Current
expert opinion is that only moderate training (3 d) is required to
make laboratory technicians already proficient in ZN smear
microscopy proficient in LED-FM. This training was provided to
study staff, involved instruction in specimen processing and
staining techniques, and included 2 d of supervised routine
microscopy during which an expert helped resolve any doubtful
results in order to instil confidence in workers. All staff reported
familiarity and confidence in their ability to perform the
technique. We believe that this kind of training is most likely
sufficient for the induction of staff in laboratories where the
technique is well established and there are experienced staff who
can provide continued mentoring. However, as stand-alone
training, after which laboratory staff are expected to maintain
performance without access to a second opinion, it is most likely
inadequate, and the development of structured and standardised
training packages and supervisory schemes is needed to support
scale up. The introduction of LED-FM therefore needs to be
accompanied by careful training, appropriate quality control, and
monitoring of the performance of LED-FM in the field.
Implementers may need to consider whether trade offs between
higher sensitivity and lower specificity are acceptable.
The study also indicates that the sensitivity and specificity of LED-
FM is independent of whether the sputum specimens are collected as
SSM or SMS. There is hardly any evidence that a particular
sequence of sputum collection increases the probability of finding TB
bacilli, and we have recently demonstrated that this is not so [7].
Although morning specimens have a higher yield (and single-smear
sensitivity), examining two spot specimens identifies equivalent
numbers of smear-positive patients as examining one spot specimen
followed by one morning specimen. SMS requires that all patients
return to provide the morning sample, while the SSM would identify
most smear-positive cases in one day. Thus, what is crucial is the
potential shortening of the process. Although many clinicians are
reluctant to rely on spot specimens due to the higher sensitivity of the
morning specimens, the 10% higher sensitivity of a single morning
specimen becomes redundant once multiple specimens are used. The
WHO has recently recommended using spot specimens (indeed spot-
spot) to allow the screening of patients in one day. However, the
change in policy was based on the evaluation of the method using ZN
smear microscopy. We now provide evidence that a frontloaded
LED-FM approach that uses two spot specimens results in the same
yield as approaches using a conventional SMS LED-FM scheme.
This seemingly small change may hold the key to improving current
microscopy services. If two smears are collected and examined on the
first day and one of them is positive, as was the case in the majority of
smear-positive cases in this study, patients would not have to return
the next day to complete the sputum submission process. If health
systems are modified to provide results on the same day, patients
could save the costs of one more visit in the diagnostic process, the
majority of smear-positive patients could be referred for treatment on
the day of consultation, and dropout rates may be reduced.
Moreover, it is important to consider the role that LED-FM can
play in the recent WHO endorsement of the new rapid, automated
nucleic acid amplification test, Xpert. It is unlikely, in the short
term, that Xpert can be scaled up and decentralized sufficiently to
replace smear microscopy as the initial diagnostic test worldwide,
even in areas with high rates of multi-drug-resistant TB or HIV-
associated TB, where Xpert is recommended as the initial
screening test. Furthermore, the WHO recommends continuing
to use smear microscopy for treatment monitoring, even in areas
served by new technologies such as TB culture, line probe assays,
and the Xpert assay. In areas without high rates of multi-drug-
resistant TB or HIV-associated TB, cost-effectiveness consider-
ations favour the use of smear microscopy as the initial diagnostic
tool, and thus the improved performance of direct smear
microscopy (and indeed a technique that facilitates faster
examination of smears) is an important step for improving
diagnostic services in LMICs, one that would reduce laboratory
workloads and facilitate the faster identification of patients with
negative smear microscopy who could undergo further tests.
Despite the reduced specificity of LED-FM, this approach still
has operational advantages that make it an attractive tool for TB
laboratory diagnosis. National control programmes introducing
new LED-FM services should monitor the performance of the
method under operational conditions, as training needs of staff
may be greater than anticipated. This study has shown that LED-
FM can play a key role in reaching WHO targets for TB detection,
reducing laboratory workloads, and ensuring poor patients’ access
to TB diagnosis and prompt treatment.
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Editors’ Summary
Background. Tuberculosis is a global public health
problem. Every year, about 1.7 million people die from this
contagious bacterial infection, and about 9 million new cases
occur, mainly in low- and middle-income countries.
Mycobacterium tuberculosis, which causes tuberculosis, is
spread in airborne droplets when people with the disease
cough or sneeze, and usually infects the lungs (pulmonary
tuberculosis). Symptoms of tuberculosis include a persistent
cough, weight loss, and night sweats. Because tuberculosis is
easily transmitted and potentially deadly, it is important that
it is diagnosed quickly and accurately and immediately
treated. The ‘‘gold standard’’ diagnostic test for tuberculosis
is mycobacterial culture (in liquid or solid medium), in which
laboratory technicians try to grow M. tuberculosis from
sputum (mucus brought up from the lungs by coughing).
However, this test is expensive, so most patients suspected
of having pulmonary tuberculosis in resource-limited
countries are investigated using sputum smear microscopy.
In this cheaper but less sensitive test, sputum samples are
‘‘smeared’’ onto microscope slides, stained with Ziehl-
Neelsen (ZN) dye, and then examined with a microscope
for the presence of M. tuberculosis.
Why Was This Study Done? With smear microscopy,
multiple samples have to be examined to increase the test’s
sensitivity (the proportion of patients with culture-positive
tuberculosis that the test detects). Because each smear
examination takes up to 10 minutes, tuberculosis diagnosis
with ZN smear microscopy creates a large laboratory
workload. A variant form of smear microscopy—light-
emitting-diode fluorescence microscopy (LED-FM)—could
reduce this workload. With LED-FM, smears stained with a
fluorescent dye can be examined in a quarter of the time it
takes to examine ZN smears. In this study, the researchers
evaluate the sensitivity and specificity (the proportion of
people with a negative smear among people without
tuberculosis; a high specificity indicates a low false-positive
rate) of LED-FM using samples collected in a trial undertaken
in four resource-limited countries (Ethiopia, Nepal, Nigeria,
and Yemen) to investigate two schemes for sputum sample
collection. In the spot-morning-spot (SMS) scheme, patients
provide an on-the-spot specimen at their initial consultation,
a specimen collected at home the next morning, and a
second on-the-spot sample when they deliver their morning
specimen. In the spot-spot-morning (SSM) scheme, patients
provide two on-the-spot samples during their first clinic visit
and a sample collected at home the next morning.
What Did the Researchers Do and Find? In the main
trial, the researchers collected sputum samples using the
SMS or SSM scheme from 6,627 patients with a cough lasting
more than two weeks. For their investigation of LED-FM, they
examined nearly 2,400 samples (half SSM and half SMS
specimens, about a quarter of which were tuberculosis
culture-positive) with both ZN smear microscopy and LED-
FM and determined the sensitivity and specificity of both
tests—with one, two, or three sputum samples per patient—
relative to mycobacterial solid culture. Single LED-FM smears
had higher sensitivity but lower specificity than single ZN
smears. The sensitivities of two LED-FM and two ZN smears
were 72.8% and 65.8%, respectively; the specificities of these
tests were 90.9% and 98.0%. The sensitivities of three LED-
FM and three ZN smears were 77% and 70.5%, respectively;
the specificities of these tests were 88.1% and 96.5%. The
sensitivity and specificity of both tests was similar for
samples collected using the SMS and the SSM schemes.
What Do These Findings Mean? These findings show
that in the resource-limited countries included in this trial,
LED-FM has a higher sensitivity but lower specificity than ZN
smear microscopy. The researchers calculate that in this
study the accuracy of three LED-FM examinations was 85%
(2,017 out of 2,355 patients were correctly classified as
infected or uninfected), whereas the accuracy of three ZN
smears was 91.8%. Thus, although LED-FM should identify
more people with tuberculosis than ZN smear microscopy,
because of its lower specificity, its use might also lead to
more people without tuberculosis being needlessly treated
for the disease. Nevertheless, provided that the introduction
of LED-FM is accompanied by appropriate training and
performance monitoring, LED-FM is an attractive potential
tool for the laboratory diagnosis of tuberculosis that,
together with a move towards the collection of two on-
the-spot smears in a single clinic visit, could ensure that poor
patients have access to timely tuberculosis diagnosis and
prompt treatment.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001057.
N Details of the parent trial in which the samples used in this
study were collected are available in a PLoS Medicine
Research Article by Cuevas et al.
N The World Health Organization provides information on all
aspects of tuberculosis, including information on tuberculosis
diagnostics; recent WHO policy statements on diagnosis of
tuberculosis are available; the Stop TB Partnership provides
information on global tuberculosis control (some information
in several languages)
N The US Centers for Disease Control and Prevention has
information about tuberculosis, including information on
the diagnosis of tuberculosis disease
N The US National Institute of Allergy and Infectious Diseases
also has detailed information on all aspects of tuberculosis
N MedlinePlus has links to further information about tuber-
culosis (in English and Spanish)
N A newWeb site dedicated to the discussion and optimization
of smear microscopy has recently been launched
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